DDX17 and acute myeloid leukemia: Our results highlighted a robust positive correlation between DDX17 and critical biological processes in AML, including proliferation, differentiation, inflammation, metastasis, epithelial-mesenchymal transition (EMT), quiescence, and angiogenesis (Fig. 8B).